BOULDER, Colo., December 09, 2025--(BUSINESS WIRE)--Enveda, a clinical-stage biotech company pioneering the discovery and development of a new generation of small-molecule drugs derived from life’s ...
ENV-294 is a clinical-stage small molecule designed to address the shared pathways underlying multiple inflammatory conditions via a first-in-class mechanism. ENV-294 entered Phase 1 studies in ...
The School of the Environment, or YSE, recently offered admission to its 125th cohort of students. Roughly 80 members of the incoming Class of 2027 traveled to New Haven, representing 26 U.S. states ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback